MANIA INDUCED BY STEROID-ADULTERATED HERBAL MEDICINE: A CASE REPORT
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i5.25640Keywords:
Adulteration, Chinese Proprietary Medicine, Dexamethasone, Herbal medicine, Mania, SteroidAbstract
Traditional herbal medicines are generally perceived as natural and safe. Nonetheless, adulteration of such complementary products, including Chinese Proprietary Medicines with undeclared drugs, notably steroids, is a recognized problem. While there are many accounts of Cushing's syndrome due to steroid content in traditional medicines, psychiatric complications caused by the similar insults are not reported throughout the literature. We report a case of acute mania after the short-term use of steroid-adulterated herbal product in a previously healthy young male. It shows that psychiatric complications can occur in such a scenario without the physical and metabolic features of Cushing's syndrome, and pharmacodynamic interaction between the herbal ingredient and adulterant is a possible factor. The case also highlights the need for awareness of culturally influenced health product consumption and its potential effects on clinical conditions, as well as the important role of a robust surveillance system for such products.
Downloads
References
West S, Kenedi C. Strategies to prevent the neuropsychiatric side-effects of corticosteroids: A case report and review of the literature. Curr Opin Organ Trans 2014, 2004;19:201-8.
Ching CK, Chen SP, Lee HH, Lam YH, Ng SW, Chen ML, et al. Adulteration of proprietary Chinese medicines and health products with undeclared drugs: Experience of a tertiary toxicology laboratory in Hong Kong. Br J Clin Pharmacol 2018;84:172-8.
Park HJ, Cho SH, Lee JH, Hwang IS, Han KM, Yoon CY, et al. Screening for corticosteroid adulterants in Korean herbal medicines. J Forensic Sci 2016;61:226-9.
Fung FY, Linn YC. Steroids in traditional Chinese medicine: What is the evidence? Singapore Med J 2017;58:115-20.
Ernst E. Serious psychiatric and neurological adverse effects of herbal medicines-a systematic review. Acta Psychiatr Scand 2003;108:83-91.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
Fardet L, Petersen I, Nazareth I. Suicidal behavior and severe neuropsychiatric disorders following glucocorticoid therapy in primary care. Am J Psychiatry 2012;169:491-7.
Naber D, Sand P, Heigl B. Psychopathological and neuropsychological effects of 8-days’ corticosteroid treatment. A prospective study. Psychoneuroendocrinology 1996;21:25-31.
Drozdowicz LB, Bostwick JM. Psychiatric adverse effects of pediatric corticosteroid use. Mayo Clin Proc 2014;89:817-34.
Warrington TP, Bostwick JM. Psychiatric adverse effects of corticosteroids. Mayo Clin Proc 2006;81:1361-7.
Cowen P, Harrison P, Burns T. Shorter Oxford Textbook of Psychiatry. 6th ed. Oxford: Oxford University Press; 2012.
Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 2013;9:30.
Joels M, Van Riel E. Mineralocorticoid and glucocorticoid receptor-mediated effects on serotonergic transmission in health and disease. Ann N Y Acad Sci 2004;1032:301-3.
Meijer OC, de Kloet ER. Corticosterone and serotonergic neurotransmission in the hippocampus: Functional implications of central corticosteroid receptor diversity. Crit Rev Neurobiol 1998;12:1- 20.
Vazquez DM, Neal CR Jr, Patel PD, Kaciroti N, Lopez JF. Regulation of corticoid and serotonin receptor brain system following early life exposure of glucocorticoids: Long term implications for the neurobiology of mood. Psychoneuroendocrinology 2012;37:421-37.
Fink G, Sumner BE, McQueen JK, Wilson H, Rosie R. Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 1998;25:764-75.
Kusljic S, Manias E, Gogos A. Corticosteroid-induced psychiatric disturbances: It is time for pharmacists to take notice. Res Soc Admin Pharm 2016;12:355-60.
Fugh-Berman A, Cott JM. Dietary supplements and natural products as psychotherapeutic agents. Psychosom Med 1999;61:712-28.
Wong AH, Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch Gen Psychiatry 1998;55:1033-44.
Bisset NG, Witchl M. Herbal Drugs and Phytopharmaceuticals. Stuttgart: Med Pharm Scientific Publishers; 1994.
Gonzalez-Seijo JC, Ramos YM, Lastra I. Manic episode and ginseng: Report of a possible case. J Clin Psychopharmacol 1995;15:447-8.
Jones BD, Runikis AM. Interaction of ginseng with phenelzine (letter). J Clin Psychopharmacol 1987;7:201.
Engelberg D, McCutcheon A, Wiseman S. A case of ginseng-induced mania. J Clin Psychophramacol 2001;21:535-7.
Avakian EV Jr, Evonuk E. Effects of Panax ginseng extract on tissue glycogen and adrenal cholesterol depletion during prolonged exercise. Planta Med 1979;36:43-8.
Prakash NK, Deepa S, Sripriya N, Bhuvaneswari S. Quality assessment for the presence of heavy metals in herbal materials from the markets of Chennai, India. Int J Pharm Pharm Sci 2014;6:574-8.
Mendonça TS, Miranda RM, Carollo CA, Mendonça SA, de Siqueira JM. Synthetic product illegally sold in Brazil as a medicinal herbal product: Chemical analysis and the patient’s medication experience. Int J Pharm Pharm Sci 2016;8:134-7.
Fan TP, DealG, Koo HL, Rees D, Sun H, Chen S, et al. Future development of global regulations of Chinese herbal products. J Ethnopharmacol 2012;140:568-86.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
